161 related articles for article (PubMed ID: 1988552)
1. [3H]harman binding experiments. I: A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat.
May T; Rommelspacher H; Pawlik M
J Neurochem; 1991 Feb; 56(2):490-9. PubMed ID: 1988552
[TBL] [Abstract][Full Text] [Related]
2. [3H]harman binding experiments. II: Regional and subcellular distribution of specific [3H]harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat.
May T; Pawlik M; Rommelspacher H
J Neurochem; 1991 Feb; 56(2):500-8. PubMed ID: 1988553
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
May T; Greube A; Strauss S; Heineke D; Lehmann J; Rommelspacher H
Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):308-17. PubMed ID: 8208308
[TBL] [Abstract][Full Text] [Related]
4. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats.
Rommelspacher H; May T; Salewski B
Eur J Pharmacol; 1994 Jan; 252(1):51-9. PubMed ID: 8149995
[TBL] [Abstract][Full Text] [Related]
5. [3H]Harman labels selectively and with high affinity the active site of monoamine oxidase (EC 1.4.3.4) subtype A (MAO-A) in rat, marmoset, and pig.
May T; Strauss S; Rommelspacher H
J Neural Transm Suppl; 1990; 32():93-102. PubMed ID: 2128516
[TBL] [Abstract][Full Text] [Related]
6. 1-Methyl-4-phenylpyridinium (MPP+) binds with high affinity to a beta-carboline binding site located on monoamine oxidase type A in rat brain.
May T
Neurosci Lett; 1993 Nov; 162(1-2):55-8. PubMed ID: 8121637
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain.
Maschauer S; Haller A; Riss PJ; Kuwert T; Prante O; Cumming P
J Neurochem; 2015 Dec; 135(5):908-17. PubMed ID: 26386360
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
Cesura AM; Bös M; Galva MD; Imhof R; Da Prada M
Mol Pharmacol; 1990 Mar; 37(3):358-66. PubMed ID: 2314388
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
Hosseini AR; Jackman GP; King PR; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):129-36. PubMed ID: 9851561
[TBL] [Abstract][Full Text] [Related]
10. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
Howe JR; Yaksh TL
Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
13. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.
Saura J; Kettler R; Da Prada M; Richards JG
J Neurosci; 1992 May; 12(5):1977-99. PubMed ID: 1578281
[TBL] [Abstract][Full Text] [Related]
14. [3H]norharman ([3H]beta-carboline) binds reversibly and with high affinity to a specific binding site in rat liver.
Greube A; Rommelspacher H
Neurochem Res; 1993 Sep; 18(9):1029-31. PubMed ID: 8232719
[TBL] [Abstract][Full Text] [Related]
15. Characterization of [3H]vesamicol binding in rat brain preparations.
Meyer EM; Bryant SO; Wang RH; Watson RJ
Neurochem Res; 1993 Oct; 18(10):1067-72. PubMed ID: 8255355
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding of [3H]SR 95531, a GABAA antagonist, to rat brain membranes.
Heaulme M; Chambon JP; Leyris R; Wermuth CG; Biziere K
J Neurochem; 1987 Jun; 48(6):1677-86. PubMed ID: 3033146
[TBL] [Abstract][Full Text] [Related]
17. [3H]tryptamine binding sites are not identical to monoamine oxidase in rat brain.
Perry DC; Grimm LJ; Kettler KG; Kellar KJ
J Neurochem; 1988 Nov; 51(5):1535-40. PubMed ID: 3139835
[TBL] [Abstract][Full Text] [Related]
18. Glycine binding to rat cortex and spinal cord: binding characteristics and pharmacology reveal distinct populations of sites.
White WF; Brown KL; Frank DM
J Neurochem; 1989 Aug; 53(2):503-12. PubMed ID: 2545818
[TBL] [Abstract][Full Text] [Related]
19. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
Renouard A; Widdowson PS; Cordi A
Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
